Skip to main content
SpringerLink
Log in

Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control

  • Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The goal of this review is to summarize information about insulin dosing software and calculators used as computerized decision support systems or electronic glucose management systems (eGMS). These are used for hospitalized, insulin-treated patients with diabetes. We describe the advantages and disadvantages and the rationale for their use.

Recent Findings

We compared commercially available insulin dosing software, namely, Glucommander™, EndoTool®, GlucoStabilizer®, and GlucoTab®, in addition to computerized order entry systems that are available in electronic health records. The common feature among these eGMS is their ability to limit occurrences of hypoglycemia while achieving and maintaining patients at target blood glucose level.

Summary

More research needs to be done examining the efficacy of eGMS in disease-specific states and their benefits and utility in preventing adverse outcomes. Their long-term benefits to health care systems are beginning to emerge in cost-saving benefits and prevention of readmissions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.

    Article  CAS  Google Scholar 

  2. • Aloi J, Bode BW, Ullal J, Chidester P, McFarland RS, Bedingfield AE, et al. Comparison of an electronic glycemic management system versus provider-managed subcutaneous basal bolus insulin therapy in the hospital setting. J Diabetes Sci Technol. 2017;11(1):12–6 This paper demonstrates the use and utility of eGMS compared with basal-bolus insulin therapy.

    Article  Google Scholar 

  3. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.

    Article  Google Scholar 

  4. Mulla CM, Lieb DC, McFarland R, Aloi JA. Tides of change: improving glucometrics in a large multihospital health care system. J Diabetes Sci Technol. 2015;9(3):602–8.

    Article  Google Scholar 

  5. Aloi JA, Mulla C, Ullal J, Lieb DC. Improvement in inpatient glycemic care: pathways to quality. Curr Diab Rep. 2015;15(4):18.

    Article  Google Scholar 

  6. Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61.

    Article  CAS  Google Scholar 

  7. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181–6.

    Article  CAS  Google Scholar 

  8. Brand DA, Peragallo-Dittko V, Fazzari MJ, Islam S, Jacobson AM, Radin MS. Changing to basal-bolus insulin therapy for the inpatient management of hyperglycemia-a natural experiment. Endocr Pract. 2019;25:836–45.

    Article  Google Scholar 

  9. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.

    Article  Google Scholar 

  10. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.

    Article  Google Scholar 

  11. Colunga-Lozano LE, Gonzalez Torres FJ, Delgado-Figueroa N, Gonzalez-Padilla DA, Hernandez AV, Roman Y, et al. Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus. Cochrane Database Syst Rev. 2018;11:CD011296.

    PubMed  Google Scholar 

  12. Basal-Bolus Versus sliding-scale insulin therapy in the acute care hospital setting: a review of comparative clinical effectiveness and cost-effectiveness. CADTH Rapid Response Reports Ottawa (ON), 2017.

  13. American Diabetes A. Diabetes care in the hospital. Diabetes Care. 2016;39(Suppl 1):S99–104.

    Google Scholar 

  14. Schroeder JE, Liebergall M, Raz I, Egleston R, Ben Sussan G, Peyser A, et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes Metab Res Rev. 2012;28(1):71–5.

    Article  CAS  Google Scholar 

  15. Colibaseanu DT, Osagiede O, McCoy RG, Spaulding AC, Habermann EB, Naessens JM, et al. Proactive protocol-based management of hyperglycemia and diabetes in colorectal surgery patients. Endocr Pract. 2018;24(12):1073–85.

    Article  Google Scholar 

  16. Rushakoff RJ, Sullivan MM, Seley JJ, Sadhu A, O’Malley CW, Manchester C, et al. Using a mentoring approach to implement an inpatient glycemic control program in United States hospitals. Healthc (Amst). 2014;2(3):205–10.

    Article  Google Scholar 

  17. Maynard G, Schnipper JL, Messler J, Ramos P, Kulasa K, Nolan A, et al. Design and implementation of a web-based reporting and benchmarking center for inpatient glucometrics. J Diabetes Sci Technol. 2014;8(4):630–40.

    Article  Google Scholar 

  18. Certification in inpatient diabetes the world wide web: the joint commission; 2019 [Available from: https://www.jointcommission.org/certification/inpatient_diabetes.aspx. Accessed 06 June 2019

  19. Goldberg PA, Bozzo JE, Thomas PG, Mesmer MM, Sakharova OV, Radford MJ, et al. “Glucometrics”--assessing the quality of inpatient glucose management. Diabetes Technol Ther. 2006;8(5):560–9.

    Article  CAS  Google Scholar 

  20. American Diabetes A. 15. Diabetes care in the hospital: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S173–S81.

    Article  Google Scholar 

  21. Draznin B, Gilden J, Golden SH, Inzucchi SE, investigators P, Baldwin D, et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care. 2013;36(7):1807–14.

    Article  Google Scholar 

  22. Alamri N, Seley JJ. Evaluation of several electronic glycemic management systems. J Diabetes Sci Technol. 2018;12(1):60–2.

    Article  Google Scholar 

  23. Ateya MB, Aiyagari R, Moran C, Singer K. Insulin bolus calculator in a pediatric hospital. Safety and user perceptions. Appl Clin Inform. 2017;8(2):529–40.

    Article  Google Scholar 

  24. Mathioudakis N, Jeun R, Godwin G, Perschke A, Yalamanchi S, Everett E, et al. Development and implementation of a subcutaneous insulin clinical decision support tool for hospitalized patients. J Diabetes Sci Technol. 2019;13(3):522–32.

    Article  Google Scholar 

  25. Decision support in Epic helps reduce insulin dosing errors by 50% Epic Systems Corporation; November 13, 2017 [Available from: https://www.epic.com/epic/post/decision-support-epic-helps-reduce-insulin-dosing-errors-50.

  26. Gianchandani R, Umpierrez GE. Inpatient use of computer-guided insulin devices moving into the non-intensive care unit setting. Diabetes Technol Ther. 2015;17(10):673–5.

    Article  Google Scholar 

  27. Mabrey ME, McFarland R, Young SL, Cooper PL, Chidester P, Rhinehart AS. Effectively identifying the inpatient with hyperglycemia to increase patient care and lower costs. Hosp Pract (1995). 2014;42(2):7–13.

    Article  Google Scholar 

  28. • Newsom R, Patty C, Camarena E, Sawyer R, McFarland R, Gray T, et al. Safely converting an entire academic medical center from sliding scale to basal bolus insulin via implementation of the eGlycemic management system. J Diabetes Sci Technol. 2018;12(1):53–9 This paper illustrates the steps that can be taken to initiate eGMS in an institution and utlity and benefits of implementing electronic glucose management.

    Article  Google Scholar 

  29. Mumpower A, Parsons T, McFarland RA, Henderson A, editors. Does glycemic control using eGMS reduce readmission rates for hospitalized patients undergoing CABG? Annual Diabetes Technology Meeting, Bethesda, MD, 2017

  30. Aloi J, Ullal J, Chidester P, McFarland R. “AUTO study” AUtomatic titration tO target: subcutaneous basal bolus insulin management using eGMS in the non-ICU setting. American Association of Clinical Endocrinologists (AACE) Annual Scientific & Clinical Congress; Austin, TX: Endocr Pract; 2017. p. 1–326.

  31. Aloi J, Chidester P, Henderson A, Booth R, McFarland R, Mumford A, et al., editors. Improved inpatient hypoglycemia rates with electronic glycemic management system. American Association of Clinical Endocrinologists (AACE) Annual Scientific & Clinical Congress; May 2016; Orlando, FL: Endocrine Practice.

  32. Juneja R, Golas AA, Carroll J, Nelson D, Abad VJ, Roudebush CP, et al. Safety and effectiveness of a computerized subcutaneous insulin program to treat inpatient hyperglycemia. J Diabetes Sci Technol. 2008;2(3):384–91.

    Article  Google Scholar 

  33. Tanenberg RJ, Hardee S, Rothermel C, Drake AJ 3rd. Use of a computer-guided glucose management system to improve glycemic control and address national quality measures: a 7-year, retrospective observational study at a tertiary care teaching hospital. Endocr Pract. 2017;23(3):331–41.

    Article  Google Scholar 

  34. Donsa K, Beck P, Holl B, Mader JK, Schaupp L, Plank J, et al. Impact of errors in paper-based and computerized diabetes management with decision support for hospitalized patients with type 2 diabetes. A post-hoc analysis of a before and after study. Int J Med Inform. 2016;90:58–67.

    Article  Google Scholar 

  35. Spat S, Donsa K, Beck P, Holl B, Mader JK, Schaupp L, et al. A mobile computerized decision support system to prevent hypoglycemia in hospitalized patients with type 2 diabetes mellitus. J Diabetes Sci Technol. 2017;11(1):20–8.

    Article  Google Scholar 

  36. Bode B, Harrison C (eds). Time to target using eGMS to manage inpatient subcutaneous insulin basal bolus regimen. International Conference on Advanced Technologies & Treatments for Diabetes; February 2017. Diabetes Technology & Therapeutics: Mary Ann Liebert Inc., Publishers

  37. Hulkower RD, Pollack RM, Zonszein J. Understanding hypoglycemia in hospitalized patients. Diabetes Manag (Lond). 2014;4(2):165–76.

    Article  CAS  Google Scholar 

  38. Ullal J, Mabrey M, Henderson A, McFarland R, Booth R, Aloi J. eGlycemic management system provides safe and effective glycemic control for stroke patients requiring subcutaneous insulin in the hospital setting. Annual Diabetes Technology Meeting; Bethesda, MD, 2015.

  39. Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson SA. Computerized clinical decision support for prescribing: provision does not guarantee uptake. J Am Med Inform Assoc. 2010;17(1):25–33.

    Article  Google Scholar 

  40. Pearson SA, Moxey A, Robertson J, Hains I, Williamson M, Reeve J, et al. Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Serv Res. 2009;9:154.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Diabetes and Endocrinology, Division of Endocrinology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Jagdeesh Ullal

  2. Department of Internal Medicine, Section on Endocrinology and Metabolism, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Joseph A. Aloi

Authors
  1. Jagdeesh Ullal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph A. Aloi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jagdeesh Ullal.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict(s) of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Health Care Delivery Systems and Implementation in Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ullal, J., Aloi, J.A. Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control. Curr Diab Rep 19, 120 (2019). https://doi.org/10.1007/s11892-019-1254-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-019-1254-y

Keywords

Search

Navigation